Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model

被引:14
|
作者
Takahashi, Bitoku [1 ]
Funami, Hideaki [1 ]
Iwaki, Takehiko [1 ]
Maruoka, Hiroshi [1 ]
Shibata, Makoto [1 ]
Koyama, Makoto [1 ]
Nagahira, Asako [1 ]
Kamiide, Yoshiyuki [1 ]
Kanki, Satomi [1 ]
Igawa, Yoshiyuki [1 ]
Muto, Tsuyoshi [1 ]
机构
[1] Asubio Pharma Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan
关键词
GhrelinR; Inverse agonist; 2-Aminoalkyl nicotinamide; Obesity; GROWTH-HORMONE SECRETION; IDENTIFICATION; POTENT; PEPTIDE;
D O I
10.1016/j.bmc.2015.05.047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 2-alkylamino nicotinamide analogs was prepared as orally active ghrelin receptor (ghrelinR) inverse agonists. Starting from compound 1, oral bioavailability was improved by modifying metabolically unstable sites and reducing molecular weight. Brain-permeable compound 33 and compound 24 with low brain permeability were tested in rat models of obesity; 30 mg/kg of compound 33 suppressed weight gain. PK/PD analysis revealed that the anti-obesity effect of ghrelinR inverse agonists depends on their brain concentrations. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4792 / 4803
页数:12
相关论文
共 50 条
  • [41] Toward the discovery of novel, orally active S1P1-selective receptor agonists
    Bolli, Martin H.
    Birker, Magdalena
    Buchmann, Stephan
    Hess, Patrick
    Kohl, Christopher
    Lescop, Cyrille
    Mathys, Boris
    Mueller, Claus
    Nayler, Oliver
    Rey, Markus
    Scherz, Michael
    Steiner, Beat
    Velker, Joerg
    Weller, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [42] Differential impact of a ghrelin receptor antagonist or inverse agonist in the electrical kindling model of epilepsy
    Beheshti, Siamak
    Ershadi, Shiva
    Zamani, Fatemeh
    Azimzadeh, Mansour
    Wesal, Mohammad Wasil
    EPILEPSY RESEARCH, 2023, 197
  • [43] THE HYPOTHYROID RAT AS A MODEL OF INCREASED SENSITIVITY TO DOPAMINE RECEPTOR AGONISTS
    CAMERON, DL
    CROCKER, AD
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) : 627 - 632
  • [44] An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis
    Hogaboam, CM
    Muller, MJ
    Collins, SM
    Hunt, RH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 309 (03) : 261 - 269
  • [45] Antiparkinsonian effects of H3 receptor inverse agonists: a behavioural study with ciproxifan in the 6-OHDA rat model
    Humbert-Claude, M.
    Guilloux, J. P.
    Arrang, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S40 - S41
  • [46] Actions of alpha adrenergic receptor agonists on rat hippocampal CA3 network activity
    Green, Kristan
    Boese, Sarah
    Xu, Ke
    Nelson, Brian
    Goldenstein, Brianna
    Davis, Kylie
    Lichter, Jessica
    Pribula, Jacqueline
    O'Brien, Jasmine
    Johnson, Jamie
    Jurgens, Chris
    Porter, James
    Doze, Van
    FASEB JOURNAL, 2007, 21 (06): : A1210 - A1210
  • [47] Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity: Validation of the Target and Identification of Novel Series
    Pierson, Pascale David
    Freichel, Christian
    Arthur, Silvia Gatti-Mac
    Hertel, Cornelia
    Huwyler, Joerg
    Mohr, Peter
    Nakagawa, Toshito
    Nettekoven, Matthias
    Plancher, Jean-Marc
    Raab, Susanne
    Richter, Hans
    Roche, Olivier
    Rodriguez Sarmiento, Rosa Maria
    Schmitt, Monique
    Schuler, Franz
    Takahashi, Tadakatsu
    Taylor, Sven
    Ullmer, Christoph
    Wiegand, Ruby
    CHIMIA, 2009, 63 (05) : 275 - 278
  • [48] DIFFERENT MOTOR ACTIONS OF DYNORPHINS AND NONPEPTIDE KAPPA OPIOID RECEPTOR AGONISTS IN THE ISOLATED RAT COLON
    SCHEURER, U
    WENGER, F
    CALIEZI, A
    DRACK, E
    VARGA, L
    HALTER, F
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (03): : 1324 - 1330
  • [49] Behavioral satiety sequence in a genetic mouse model of obesity: effects of ghrelin receptor ligands
    Finger, Beate C.
    Dinan, Timothy G.
    Cryan, John F.
    BEHAVIOURAL PHARMACOLOGY, 2011, 22 (07): : 624 - 632
  • [50] AN ORALLY ACTIVE INHIBITOR OF LEUKOTRIENE SYNTHESIS ACCELERATES HEALING IN A RAT MODEL OF COLITIS
    WALLACE, JL
    KEENAN, CM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04): : G527 - G534